About this trial
This clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors. Golf is a multimodal recreational activity that requires participants to utilize all muscle groups to perform the golf swing, walk over hilly and uneven terrain, maintain balance during putting and squat-like tasks. Physical activity and exercise are beneficial to physical function, cognitive function, psychosocial health, and overall quality of life during prostate cancer survivorship. These aspects of health are impacted by prostate cancer treatment, especially androgen deprivation therapy. Additionally, supervised, group-based activity programs facilitate participation in physical activity. Researchers want to examine the changes in functional abilities, psychosocial health, and quality of life following participation in in a golf program designed for prostate cancer survivors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
First time, primary diagnosis of prostate cancer (PCa)
Currently receiving androgen deprivation therapy (ADT) and/or androgen receptor blocker) for more than 6 months
Older adult male: 55-85 years old
The ability to stand independently without external support
Disqualifiers
Second cancer diagnosis (excluding non-invasive skin cancers) or bone metastases
Prostatectomy less than 6 months prior to study enrollment (prostatectomy is not a requirement for study entry)
Symptomatic cardiovascular disease, active angina, uncontrolled hypertension (systolic blood pressure (SBP) > 160 or diastolic blood pressure (DBP) > 90, high resting pulse heart rate (HR) > 90), symptomatic orthostatic hypotension
Unstable asthma, exacerbated chronic obstructive pulmonary disease (COPD]
Trial design
Single group
Treatments tested in this trial
Biospecimen Collection
Procedure/SurgeryUndergo blood sample collection
Discussion
Procedure/SurgeryAncillary studies
Exercise Intervention
Other interventionComplete golf related exercises
Interview
Other interventionAncillary studies
Medical Device Usage and Evaluation
Other interventionWear activity tracker
Physical Examination
Procedure/SurgeryAncillary studies
Physical Performance Testing
Other interventionAncillary studies
Questionnaire Administration
Other interventionAncillary studies
Recreational Therapy
Other interventionParticipate in golf program
Treatment groups
Trial outcomes
Primary outcomes
Enrollment rate
Will be defined as the final number of enrolled individuals / the number of qualified individuals screened.
Participant adherence to the program
Will be assessed by the number of participants who adhere to the study and attend \> 80% of supervised training sessions.
Cost of the program
Will be assessed by the cost that the program will be \< $1,000/participant.
Staff adherence
Will be assessed by trained staff who attend \> 90% of scheduled sessions.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Southern California
Lead sponsor
National Cancer Institute (NCI)
Collaborator